Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials

Wei Zhang, Ye Wang, Shu Yan Cong, Jian Fei Nao, Juan Feng, Guo Rong Bi Neurology Department, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China Abstract: Primary restless leg syndrome (RLS) is a common sensory-motor disorder that is characterized by an irr...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zhang W, Wang Y, Cong SY, Nao JF, Feng J, Bi GR
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/d86d5ad4d3d24fa39bf5f61cac664e5b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:d86d5ad4d3d24fa39bf5f61cac664e5b
record_format	dspace
spelling	oai:doaj.org-article:d86d5ad4d3d24fa39bf5f61cac664e5b2021-12-02T02:08:11ZEfficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials1176-63281178-2021https://doaj.org/article/d86d5ad4d3d24fa39bf5f61cac664e5b2013-07-01T00:00:00Zhttp://www.dovepress.com/efficacy-and-tolerability-of-pramipexole-for-the-treatment-of-primary--a13842https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Wei Zhang, Ye Wang, Shu Yan Cong, Jian Fei Nao, Juan Feng, Guo Rong Bi Neurology Department, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China Abstract: Primary restless leg syndrome (RLS) is a common sensory-motor disorder that is characterized by an irresistible urge to move the limbs and unpleasant sensations in the legs, which affects 1.9%–4.6% adults. Pramipexole, a potent dopamine D2/3 agonist, is recommended as “effective” in the short-term and “possibly effective” in the long-term treatment of primary RLS in the European guidelines on management of RLS. In this meta-analysis, we summarized the efficacy and tolerability of pramipexole in treatment for primary RLS. Results of this meta-analysis showed a favorable effect of pramipexole versus placebo on RLS symptoms (mean change on International RLS Study Group Rating Scale [IRLS] score: mean difference [MD] = -5.96; 95% confidence interval [CI]: -7.79 to -4.41, P < 0.00001) and sleep quality (pooled standard mean difference [SMD] = -0.48, 95% CI: -0.61 to -0.35, P < 0.00001). Nausea (relative risk [RR] = 2.68, 95% CI: 1.82 to 3.95, P < 0.001) and fatigue (RR = 1.82, 95% CI: 1.14 to 2.93, P = 0.013) were the most common adverse events, but, by and large, pramipexole was well-tolerated in patients with primary RLS. Nevertheless, long-term studies and more evidence of head-to-head comparisons of pramipexole with other dopamine agonists, anticonvulsants, and levodopa are needed. Keywords: restless legs syndrome, pramipexole, meta-analysisZhang WWang YCong SYNao JFFeng JBi GRDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 1035-1043 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Zhang W Wang Y Cong SY Nao JF Feng J Bi GR Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
description	Wei Zhang, Ye Wang, Shu Yan Cong, Jian Fei Nao, Juan Feng, Guo Rong Bi Neurology Department, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China Abstract: Primary restless leg syndrome (RLS) is a common sensory-motor disorder that is characterized by an irresistible urge to move the limbs and unpleasant sensations in the legs, which affects 1.9%–4.6% adults. Pramipexole, a potent dopamine D2/3 agonist, is recommended as “effective” in the short-term and “possibly effective” in the long-term treatment of primary RLS in the European guidelines on management of RLS. In this meta-analysis, we summarized the efficacy and tolerability of pramipexole in treatment for primary RLS. Results of this meta-analysis showed a favorable effect of pramipexole versus placebo on RLS symptoms (mean change on International RLS Study Group Rating Scale [IRLS] score: mean difference [MD] = -5.96; 95% confidence interval [CI]: -7.79 to -4.41, P < 0.00001) and sleep quality (pooled standard mean difference [SMD] = -0.48, 95% CI: -0.61 to -0.35, P < 0.00001). Nausea (relative risk [RR] = 2.68, 95% CI: 1.82 to 3.95, P < 0.001) and fatigue (RR = 1.82, 95% CI: 1.14 to 2.93, P = 0.013) were the most common adverse events, but, by and large, pramipexole was well-tolerated in patients with primary RLS. Nevertheless, long-term studies and more evidence of head-to-head comparisons of pramipexole with other dopamine agonists, anticonvulsants, and levodopa are needed. Keywords: restless legs syndrome, pramipexole, meta-analysis
format	article
author	Zhang W Wang Y Cong SY Nao JF Feng J Bi GR
author_facet	Zhang W Wang Y Cong SY Nao JF Feng J Bi GR
author_sort	Zhang W
title	Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
title_short	Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
title_full	Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
title_fullStr	Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
title_full_unstemmed	Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
title_sort	efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/d86d5ad4d3d24fa39bf5f61cac664e5b
work_keys_str_mv	AT zhangw efficacyandtolerabilityofpramipexoleforthetreatmentofprimaryrestlesslegsyndromeametaanalysisofrandomizedplacebocontrolledtrials AT wangy efficacyandtolerabilityofpramipexoleforthetreatmentofprimaryrestlesslegsyndromeametaanalysisofrandomizedplacebocontrolledtrials AT congsy efficacyandtolerabilityofpramipexoleforthetreatmentofprimaryrestlesslegsyndromeametaanalysisofrandomizedplacebocontrolledtrials AT naojf efficacyandtolerabilityofpramipexoleforthetreatmentofprimaryrestlesslegsyndromeametaanalysisofrandomizedplacebocontrolledtrials AT fengj efficacyandtolerabilityofpramipexoleforthetreatmentofprimaryrestlesslegsyndromeametaanalysisofrandomizedplacebocontrolledtrials AT bigr efficacyandtolerabilityofpramipexoleforthetreatmentofprimaryrestlesslegsyndromeametaanalysisofrandomizedplacebocontrolledtrials
_version_	1718402680171266048

Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials

Documents similaires